Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.500
0.00 (0.00%)
Apr 15, 2026, 4:00 PM EST
Nuo Therapeutics Revenue
In the year 2025, Nuo Therapeutics had annual revenue of $3.31M with 142.72% growth. Nuo Therapeutics had revenue of $1.10M in the quarter ending December 31, 2025, with 177.77% growth.
Revenue
3.31M
Revenue Growth
+142.72%
P/S Ratio
21.86
Revenue / Employee
331.35K
Employees
10
Market Cap
72.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.31M | 1.95M | 142.72% |
| Dec 31, 2024 | 1.37M | 756.65K | 124.34% |
| Dec 31, 2023 | 608.53K | 496.28K | 442.12% |
| Dec 31, 2022 | 112.25K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vaxart | 237.26M |
| BioStem Technologies | 47.48M |
| Harvard Apparatus Regenerative Technology | 704.00K |
| Silence Therapeutics | 559.00K |
| Zenith Capital | 500.00K |
| Provectus Biopharmaceuticals | 336.11K |
| Arch Biopartners | 115.29K |
Nuo Therapeutics News
- 1 year ago - Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew - GlobeNewsWire
- 1 year ago - Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies - GlobeNewsWire
- 3 years ago - Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange - GlobeNewsWire
- 3 years ago - Nuo Therapeutics' Aurix® System Added To Wound Care Formulary Of Wound Care Advantage - GlobeNewsWire
- 3 years ago - Nuo Therapeutics Provides Corporate and Business Update - GlobeNewsWire